T-CELL LYMPHOMA STAGE IV

T-CELL LYMPHOMA STAGE IV was reported 57 times

T-CELL LYMPHOMA STAGE IV is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD30-directed Immunoconjugate [EPC] 8 0.0008
1 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 8 0.0004
2 Alkylating Drug [EPC] 26 0.0001
3 Quinolone Antimicrobial [EPC] 1 0.0001
4 Antirheumatic Agent [EPC] 10 0.0001
5 Topoisomerase Inhibitor [EPC] 6 0.0001
6 Purine Antimetabolite [EPC] 5 0.0001
7 Aminosalicylate [EPC] 5 0.0000
8 Antimetabolite Immunosuppressant [EPC] 1 0.0000
9 Platinum-based Drug [EPC] 8 0.0000
10 Nucleoside Metabolic Inhibitor [EPC] 8 0.0000
11 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
12 Corticosteroid [EPC] 34 0.0000
13 Folate Analog [EPC] 1 0.0000
14 Vitamin A [EPC] 1 0.0000
15 Methylxanthine [EPC] 1 0.0000
16 Nicotinic Acid [EPC] 1 0.0000
17 Tumor Necrosis Factor Blocker [EPC] 16 0.0000
18 Antidote [EPC] 1 0.0000
19 Proton Pump Inhibitor [EPC] 8 0.0000
20 Loop Diuretic [EPC] 6 0.0000
21 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
22 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
23 Integrin Receptor Antagonist [EPC] 1 0.0000
24 Anti-IgE [EPC] 1 0.0000
25 Central Nervous System Stimulant [EPC] 1 0.0000
26 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
27 Aldosterone Antagonist [EPC] 1 0.0000
28 Interferon beta [EPC] 1 0.0000
29 RANK Ligand Inhibitor [EPC] 1 0.0000
30 Retinoid [EPC] 1 0.0000
31 Platelet Aggregation Inhibitor [EPC] 2 0.0000
32 Vitamin D [EPC] 1 0.0000
33 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
34 Vitamin B12 [EPC] 1 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
36 Vitamin C [EPC] 1 0.0000
37 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000